Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools
Michelle R. Downes(Sunnybrook Health Science Centre), Theodorus van der Kwast(Erasmus MC), Lisa J Kroon(Erasmus MC Cancer Institute), Yanhong Yu(Severance Hospital), Eva Hollemans(Erasmus MC), Katherine Lajkosz(University Health Network), Geert J.L.H. van Leenders(Erasmus MC Cancer Institute), Antonio Finelli(University Health Network), Kenneth A. Iczkowski(University of California, Davis), Kristen Liu(Medical College of Wisconsin), Neil Fleshner(Princess Margaret Cancer Centre)
Cited by 10
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705